Diabetes therapy management software company Glytec has just secured its fourth FDA clearance, adding a slew of capabilities to its Glucommander product, the core of its eGlycemic Management System.
New KLAS First Look report highlights customer-reported improvements in patient safety, insulin dosing accuracy, and hypoglycemia reduction. The report, titled "Glytec Glucommander 2025: Using ...
BOSTON, Sept. 16, 2025 /PRNewswire/ -- Glytec, the leading provider of an AI-powered diabetes platform for hospitals and health systems, today announced that Healthcare Tech Outlook named Glytec its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results